Research brings new hope for Amyotrophic Lateral Sclerosis
To mark Brain Awareness Week, Luc Dupuis, Director of UMR-S 1329, was a guest on the “Focus en Alsace” program on RFC Alsace radio.
What if the first signs of ALS were found... in sleep?
In a video interview with Inserm, Matei Bolborea discusses the findings of a recently published paper suggesting that detailed sleep analysis could serve as an early indicator of ALS progression.
11th French ALS and MND Research Days
Isabelle Weber rewarded at the 11th French ALS and MND Research Days.
Brain Week
Held every year in March, Brain Week is an international event organized simultaneously in some 100 countries and over 120 towns in France, to raise public awareness of the importance of brain research.
Amyotrophic Lateral Sclerosis: sleep disorders precede the onset of motor symptoms
Sleep disorders are well known in several neurodegenerative diseases, but remain little studied in the case of amyotrophic lateral sclerosis (ALS). In this new study by Guillot, Lang et al., the authors focus on sleep changes and imbalances in hypothalamic signals in ALS patients. Using sleep…
NeuroStra Scientific Day 2024
Marina Hernán Godoy and LingYi Zhang, both PhD students in the ALS-FTD team, awarded at the NeuroStra Scientific Day 2024.
Visit of Olivier Goy, president of ARSLA
On the 6th of November 2024, Olivier Goy, President of ARSLA (Amyotrophic Lateral Sclerosis Research Association) visited the CRBS accompanied by Claude Desnuelle (ARSLA Vice-President and neurologist) and their team to meet the ALS-FTD team, dedicated to research into this disease. During his…
Foundation for Medical Research Prize
Caroline Rouaux, winner of the Fabrice Le Mouhaër Prize from the French Foundation for Medical Research
10th French ALS and MND Research Days
Marina Hernán Godoy rewarded at the 10th French ALS and MND Research Days
Ice Bucket Challenge against ALS 2024
10 years after the viral phenomenon of the Ice Bucket Challenge, designed to raise media awareness and funds for the fight against Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease (known in France as Charcot's disease), the challenge is back in France, on the initiative of Les…
Establishment of an ALS patient cohort
The FG-COALS project - Franco-German cohort study on factors associated with weight loss in ALS - led by Luc Dupuis (CRBS - INSERM Unit 1118) and Philippe Couratier (CHU Limoges) has been awarded €1.3M in funding from the Programme investissements d'avenir (PIA 3).